Veeva & Anthill AI Partnership

Anthill

/@helloanthill

Published: June 24, 2024

Open in YouTube
Insights

This video details the strategic partnership between Anthill and Veeva Solutions, positioning Anthill as an official Veeva AI partner. This collaboration leverages Anthill’s generative AI platform, Arcane, to enhance content management and operational efficiency within the pharmaceutical industry by deeply integrating GenAI capabilities into core Veeva platforms, specifically PromoMats (for promotional materials) and MedComs (for medical communications). The partnership aims to solve critical industry challenges related to content localization, reuse, compliance, and rapid response times for both commercial and medical affairs teams.

The Arcane platform is designed to act as an intelligent layer over a company's approved content within Veeva systems. It allows users to pose complex, strategic business questions and retrieve validated answers directly from unstructured data and modular content. This capability moves beyond simple search functionality, enabling users to explore and identify valuable information quickly, and crucially, to work with modular content to create new tactical materials through a simple, conversational interface. This approach is intended to make content assembly for personalized and localized campaigns scalable and efficient.

A significant focus of the platform is addressing the global content lifecycle. Arcane features robust translation capabilities, allowing documents—including standard formats like Word, PowerPoint, Excel, and HTML files used for detailing and email—to be translated into over 30 different languages. This dramatically accelerates the process of bringing approved materials down to local markets, a major bottleneck in global pharmaceutical commercial operations. Furthermore, the platform streamlines content creation by combining existing design systems and templates with unstructured or modular content, enabling the creation of compliant emails in minutes.

Beyond commercial applications, Arcane provides essential support for Medical Affairs. It is engineered to accelerate responses to medical information inquiries by rapidly extracting relevant data from complex clinical studies. This functionality also extends to supporting or refuting claims an organization wishes to make, ensuring that all communications are grounded in approved, verifiable data. The platform’s development followed a co-creation model with industry partners, ensuring that the use cases and features implemented provide immediate, real-world value within the highly regulated life science environment.

Key Takeaways: • Veeva’s Formal AI Endorsement: The partnership signals Veeva’s formal acceptance and integration of third-party generative AI solutions into its core content management ecosystem (PromoMats and MedComs), setting a new standard for AI adoption in regulated content workflows. • GenAI as a Strategic Query Layer: Anthill’s Arcane platform functions as a sophisticated Retrieval-Augmented Generation (RAG) system, allowing users to ask complex, strategic questions against their entire repository of approved Veeva content, transforming unstructured data into actionable intelligence. • Focus on Modular Content: The platform emphasizes working with modular content, validating the industry trend toward atomic content components as the foundation for scalable, personalized, and compliant GenAI-driven content creation. • High-Value Localization Use Case: The ability to translate detailing and email materials (in formats like Word, PPT, Excel, HTML) into over 30 languages rapidly addresses a critical pain point for global pharma companies, significantly reducing time-to-market for localized campaigns. • Accelerated Medical Information Response: Arcane directly supports Medical Affairs by automating the extraction of data from clinical studies and speeding up the response time for medical information inquiries, a key area for compliance and HCP engagement. • Streamlined Commercial Content Assembly: The platform simplifies the creation of new marketing tactics by allowing users to assemble content via a simple conversational interface, lowering the technical barrier for marketing and sales operations teams. • Compliance-Focused Claim Support: The AI assists in compliance by helping organizations support or refute claims based on verifiable data extracted directly from approved source materials, reinforcing the need for AI solutions to operate within regulatory guardrails. • Rapid Email Generation: By integrating design systems and templates with content, Arcane enables the creation of branded, compliant emails in minutes, drastically improving the efficiency of sales operations and marketing automation workflows. • Co-Creation Development Model: The platform's development through co-creation with industry partners suggests a focus on validated, high-impact use cases specific to the pharmaceutical workflow, rather than generic AI applications. • Competitive Landscape Shift: This partnership establishes a highly integrated, specialized competitor offering in the Veeva/GenAI space, requiring other AI consulting firms to differentiate their offerings, perhaps by focusing on deeper data engineering, custom LLM fine-tuning, or broader clinical operations support.

Tools/Resources Mentioned:

  • Veeva PromoMats
  • Veeva MedComs
  • Anthill Arcane (Generative AI platform)

Key Concepts:

  • Veeva AI Partner: A formal designation by Veeva Solutions indicating a deep integration and endorsement of a third-party AI platform within the Veeva ecosystem.
  • Modular Content: Content broken down into small, reusable, and compliant components (modules) that can be assembled quickly to create various marketing or medical materials.
  • Generative AI (GenAI): Artificial intelligence capable of generating new content, such as text, images, or code, based on learned patterns from existing data (in this case, approved Veeva content).
  • Medical Info Inquiries: Requests from healthcare professionals (HCPs) or patients for detailed, non-promotional information about a drug or medical product, typically handled by Medical Affairs.